-->

[Breaking News] Premium Alert (LSDI) $1.78 gets $5.65 Target Price Analysts Morningstar

Post a Comment

Lucy Scientific Discovery, Inc. (Ticker: LSDI)

"Accelerates" Their Revenue Stream - Stock Price Surge?


(LSDI) Priced at $1.78 Gets Target Price of $5.65 by Morningstar - Proof Here


CATALYST: Transitions To Revenue Generating Company


10XProTrader Member,


Interested in your stock doubling in price?


If you said YES, to that... Analysts from Morningstar predict (LSDI) has the legs to reach $5.65/share!


You asked for a double, take a look..


Morningstar reported that LSDI stock is appreciably undervalued. They model the fair value of LSDI to be $5.65. See Proof Here


LSDI is currently surging up at $1.78, and with one of the most respected companies in the financial markets signaling a potentially bullish trajectory, the path of least resistance for Lucy Scientific Discovery could be to the significant upside. Over 125% from current prices.

One Tiny Company Has Positioned Itself To Dominate

The Manufacturing & Research of Psychotropic Drugs


About Lucy Scientific Discovery Inc.

website: www.lucyscientific.com
Lucy Scientific Discovery Inc. [NASDAQ:LSDI] an early-stage psychedelics manufacturing company that is focused on becoming the premier research, development, and manufacturing organization for the emerging psychedelics-based medicines industry.


Lucy maintains a Controlled Drugs and Substances Dealer's License under Part J of the Food and Drug Regulations promulgated under the Food and Drugs Act (Canada), more commonly known as a Dealer's License, that was issued to Lucy by Health Canada's Office of Controlled Substances.


This Dealer's License authorizes the Company to develop, sell, deliver, and manufacture (through extraction or synthesis) certain pharmaceutical-grade active pharmaceutical ingredients, or APIs, used in controlled substances and their raw material precursors.


This Stock is an absolute Game-Changer for Investors.

Kevin Vander
Publisher, 10XProTrader.com Investment Research


Sources:

Legal Entity Information: 10XProTrader is a website owned and operated by 10XPublishing, LLC., which is a DBA of 10XMedia, LLC.


You are receiving this e-mail as part of your subscription to 10XProTrader. Please do not reply to this e-mail as this address is not monitored.


Help line: Customer service number is 1-800-803-4811

Mailing Address: Attn: Member Services | 10XMedia, LLC.
340 Royal Poinciana Way Suite 317-#409 Palm Beach, FL 33480


Our Customer Service team is available Monday - Friday between 9:00 AM and 5:00 PM ET.

© 2023 10XMedia, LLC. All Rights Reserved. Nothing in this email should be considered personalized financial advice. Although our employees may answer your general customer service questions, they are not licensed under securities laws to address your particular investment situation. No communication by our employees to you should be deemed as personalized financial advice. We expressly forbid our writers from having a financial interest in any security recommended to our readers.

© 2023 10XProTrader.com, All Rights Reserved. 10XProTrader is a financial publisher that does not offer any personal financial advice or advocate the purchase or sale of any security or investment for any specific individual. This communication is a paid advertisement. 10XProTrader.coms is owned and operated by 10XMedia LLC, which is a Florida based Limited Liability Company and/or its subsidiaries and/or affiliates ("Company," "we," or "us") have been compensated $20,000 USD to disseminate this communication. Please review the full disclaimer at https://10xprotrader.com/disc-laimer for important information about this advertisement.

Related Posts

There is no other posts in this category.

Post a Comment

Subscribe Our Newsletter